至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Glycine Substitution at Helix-to-Coil Transitions Facilitates the Structural Determination of a Stabilized Subtype C HIV Envelope Glycoprotein.

Immunity. 2017; 
GuenagaJavier,GarcesFernando,de ValNatalia,StanfieldRobyn L,DubrovskayaViktoriya,HigginsBrett,CarretteBarbara,WardAndrew B,WilsonIan A,WyattRicha
Products/Services Used Details Operation
Peptide Synthesis  The V3 peptide (TRPNNNTRKSIRIGPGQTFYATGDIIGNIRQAY) based on the 16055 V3 sequence was synthesized by Genscript. Get A Quote

摘要

Advances in HIV-1 envelope glycoprotein (Env) design generate native-like trimers and high-resolution clade A, B, and G structures and elicit neutralizing antibodies. However, a high-resolution clade C structure is critical, as this subtype accounts for the majority of HIV infections worldwide, but well-ordered clade C Env trimers are more challenging to produce due to their instability. Based on targeted glycine substitutions in the Env fusion machinery, we defined a general approach that disfavors helical transitions leading to post-fusion conformations, thereby favoring the pre-fusion state. We generated a stabilized, soluble clade C Env (16055 NFL) and determined its crystal structure at 3.... More

关键词

Antibody,Envelope glycoprotein,Glycan shield,HIV,Immunogen,Trimer,Vaccine,